Rayzebio Inc (RYZB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 21,651 | 0 | 0 | 20,950 | 0 |
| Operating Income | -21,651 | N/A | N/A | -20,950 | N/A |
| Other Income | 3,460 | 0 | 0 | 503 | 0 |
| Pre-tax Income | -18,191 | 0 | 0 | -20,447 | 0 |
| Net Income Continuous | -18,191 | N/A | N/A | -20,447 | N/A |
| Net Income | $-18,191 | $N/A | $N/A | $-20,447 | $N/A |
| EPS Basic Total Ops | -1.26 | N/A | N/A | -6.55 | N/A |
| EPS Basic Continuous Ops | -1.18 | N/A | N/A | -5.36 | N/A |
| EPS Diluted Total Ops | -1.26 | N/A | N/A | -6.55 | N/A |
| EPS Diluted Continuous Ops | -1.18 | N/A | N/A | -5.36 | N/A |
| EPS Diluted Before Non-Recurring Items | -1.26 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-23,420 | $N/A | $N/A | $-20,543 | $N/A |